SZSE:000999's EV-to-Revenue is ranked better than 54.29% of 1026
companies
in the Drug Manufacturers industry
Industry Median: 2.3
vs SZSE:000999: 2.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
China Resourcesnjiu Medical & Pharmaceutical Co EV-to-Revenue Chart
China Resourcesnjiu Medical & Pharmaceutical Co Annual Data
Competitive Comparison of China Resourcesnjiu Medical & Pharmaceutical Co's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, China Resourcesnjiu Medical & Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resourcesnjiu Medical & Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry
China Resourcesnjiu Medical & Pharmaceutical Co's current Enterprise Value is ¥54,233 Mil.
China Resourcesnjiu Medical & Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥25,681 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) EV-to-Revenue Explanation
China Resourcesnjiu Medical & Pharmaceutical Co's share price for today is ¥60.79.
China Resourcesnjiu Medical & Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥26.19.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resourcesnjiu Medical & Pharmaceutical Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Business Description
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:000999 has been successfully added to your 